Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study
Titel:
Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study
Auteur:
Hart, Lowell L. Ferrarotto, Renata Andric, Zoran G. Beck, J. Thaddeus Subramanian, Janakiraman Radosavljevic, Davorin Z. Zaric, Bojan Hanna, Wahid T. Aljumaily, Raid Owonikoko, Taofeek K. Verhoeven, Didier Xiao, Jie Morris, Shannon R. Antal, Joyce M. Hussein, Maen A.